Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare
Arbutus Biopharma Corporation Total Assets 2011–2025
Arbutus Biopharma Corporation annual total assets history from 2013 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Arbutus Biopharma Corporation total assets as of December 31, 2025: 94.6M, a 28.16% decrease year-over-year.
- Arbutus Biopharma Corporation total assets for 2025 were 94.6M, a 28.16% decrease from 2024.
- Arbutus Biopharma Corporation total assets for 2024 were 131.7M, a 8.79% decrease from 2023.
- Arbutus Biopharma Corporation total assets for 2023 were 144.4M, a 26.11% decrease from 2022.
- Arbutus Biopharma Corporation total assets for 2022 were 195.4M.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Arbutus Biopharma Corporation Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $95 |
| 2024 | $132 |
| 2023 | $144 |
| 2022 | $195 |
| 2021 | $204 |
| 2020 | $137 |
| 2019 | $106 |
| 2018 | $228 |
| 2017 | $237 |
| 2016 | $276 |
| 2015 | $712 |
| 2014 | $118 |
| 2013 | $72 |
Arbutus Biopharma Corporation Total Assets — FAQ
Arbutus Biopharma Corporation (ABUS) total assets over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABUS's total assets history?
The chart and table above show Arbutus Biopharma Corporation's total assets by year and by quarter, including the growth rate.